PRTG Company Profile and Key Details
Portage Biotech Inc.
PRTG Stock Price Chart
Stock Price Today
Portage Biotech Inc. (PRTG) stock declined over -0.24%, trading at $4.10 on NASDAQ, down from the previous close of $4.11. The stock opened at $4.06, fluctuating between $4.01 and $4.15 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
Company Information
| Employees | 7 |
| Beta | 99.48 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | March |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Portage Biotech Inc. (NASDAQ: PRTG) stock price is $4.10 in the last trading session. During the trading session, PRTG stock reached the peak price of $4.15 while $4.01 was the lowest point it dropped to. The percentage change in PRTG stock occurred in the recent session was -0.24% while the dollar amount for the price change in PRTG stock was -$0.01.
The NASDAQ listed PRTG is part of Biotechnology industry that operates in the broader Healthcare sector. Portage Biotech Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Justin Fairchild
Vice President of Devel.
Mr. Allan J. Lee Shaw CPA
Chief Financial Officer
Mr. Allan J. Lee Shaw C.P.A.
Chief Financial Officer
Mr. Brian Wiley
Chief Bus. Officer
Mr. Joseph Ciavarella
Chief Accounting Officer
Dr. Ian B. Walters M.B.A., M.D.
Chief Executive Officer & Chairman of Board
Mr. Steven Innaimo
Vice President of Project Management & Operations
Dr. Robert A. Kramer Ph.D.
Chief Scientific Officer
PRTG's closing price is 95.24% higher than its 52-week low of $2.10 where as its distance from 52-week high of $23.01 is -82.18%.
Number of PRTG employees currently stands at 7.
Official Website of PRTG is: https://www.portagebiotech.com
PRTG could be contacted at phone 203 221 7378 and can also be accessed through its website. PRTG operates from Craigmuir Chambers, Tortola, VG1110, Virgin Islands, British.
PRTG stock volume for the day was 5.13K shares. The average number of PRTG shares traded daily for last 3 months was 679.43K.
The market value of PRTG currently stands at $4.60M with its latest stock price at $4.10 and 1.12M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com